From startups to legacy brands, you're making your mark. We're here to help.
Key Links
Prepare for future growth with customized loan services, succession planning and capital for business equipment.
Key Links
Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.
Key Links
Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.
Your partner for commerce, receivables, cross-currency, working capital, blockchain, liquidity and more.
Key Links
A uniquely elevated private banking experience shaped around you.
Whether you want to invest on your own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.
For Companies and Institutions
From startups to legacy brands, you're making your mark. We're here to help.
Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.
Your partner for commerce, receivables, cross-currency, working capital, blockchain, liquidity and more.
Prepare for future growth with customized loan services, succession planning and capital for business equipment.
Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.
For Individuals
A uniquely elevated private banking experience shaped around you.
Whether you want to invest on you own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.
Explore a variety of insights.
Key Links
Insights by Topic
Explore a variety of insights organized by different topics.
Key Links
Insights by Type
Explore a variety of insights organized by different types of content and media.
Key Links
We aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.
Key Links
Shanghai, October 14, 2024 – J.P. Morgan will host its fourth Global Healthcare Shanghai Conference on October 14 and October 15.
As part of International Biopharma Industry Week Shanghai 2024, the conference will bring together global experts in healthcare investment and research, to discuss the outlook and key themes for the healthcare sector in Asia Pacific and globally. Topics will include new technology and innovation, as well as capital market opportunities. Over 160 one-on-one or small group meetings will be held in parallel to the plenary session.
Rita Chan, Co-SCO for J.P. Morgan China, said: “China’s healthcare market is the second largest in the world and offers significant investment opportunities. Drawing on our deep insights and expertise within this critical sector, J.P. Morgan is pleased to host the Global Healthcare Shanghai Conference for the fourth consecutive year, providing a unique platform to connect China’s and the global healthcare sectors.”
Alan Ho, Co-SCO for J.P. Morgan China, said: “This year’s conference is hosted at a time when China has recently announced new policies to open up the healthcare sector further. These measures are expected to foster more collaboration between Chinese and foreign companies, creating opportunities for global investors to tap into China’s healthcare industry. It’s believed that these new initiatives will also strengthen the connections between China’s healthcare market and the world, providing more positive sentiment and further accelerating the sector’s transformation and development.”
As an important hub for the healthcare industry in China, Shanghai also has recently issued new policies to support the development of its biopharma industry. Shanghai has formed a complete biopharma industry chain with more than 80,000 companies, with over 30 of them listed on the Shanghai Stock Exchange STAR Market. Over the past three years, Shanghai's innovative pharmaceutical companies have ranked top in China for both the number of financing transactions and the total amount of financing received.
David PW Lau, co-head of China Investment Banking and co-head of Asia Healthcare Investment Banking at J.P. Morgan, said: " Investors continue to be interested in healthcare companies that have the potential to go global and those with best-in-class technology platforms. Chinese companies are well positioned to combine overseas resources and domestic production advantages, further enhancing their international competitiveness. Financing plays an important role in the development of healthcare companies and as one of the leading investment banks in the global and China’s healthcare industry, we will continue to utilize our domestic and global platforms, networks and resources, in order to fully support our clients at all stages of their development.”
J.P. Morgan is the host of the world’s largest healthcare investment symposium – the J.P. Morgan Healthcare Conference, held in San Francisco every year. This premier conference is recognized as the leading conference of its kind in the industry. This year, the 42nd edition of the conference brought together more than 600 companies, both public and private, as well as 8000 delegates.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.